Hereditary Angioedema
NHS National Framework Agreement for the supply of products for the management of Hereditary Angioedema. Period of framework agreement: 1 July 2022 to 31 December 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be no more than 48 months
Buyer
NHS England
Value
£74,500,000
Published
20 Jul 2022
Closes
16 Mar 2022
Procurement details
Source
Contracts Finder
Region
London
Procurement method
Open
Category
Goods
Contract starts
30 Jun 2022
Contract ends
31 Dec 2023
CPV classifications
33600000
Pharmaceutical products
Lots
Lot default Hereditary Angioedema
£74,500,000
NHS National Framework Agreement for the supply of products for the management of Hereditary Angioedema. Period of framework agreement: 1 July 2022 to 31 December 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be no...
Delivery: England · United Kingdom, Guernsey, Isle of Man, Jersey, Northern Ireland · United Kingdom, Scotland · United Kingdom
Documents
Unlock document linkAwarded contract notice on Contracts Finder
20 Jul 2022
Awarded contract notice on Contracts Finder
Award notice · Web page
Document No. 03 - Framework Agreement and Terms and Conditions (REDACTED)
Not provided
Document No. 03 - Framework Agreement and Terms and Conditions (REDACTED)
Document
FTS Award [contact phone hidden]
Not provided
FTS Award [contact phone hidden]
Document
AWARD SCHEDULE (REDACTED) - Accord-UK Ltd#2
Not provided
AWARD SCHEDULE (REDACTED) - Accord-UK Ltd#2
Document
AWARD SCHEDULE (REDACTED) - Celix Pharma Ltd#2
Not provided
AWARD SCHEDULE (REDACTED) - Celix Pharma Ltd#2
Document
AWARD SCHEDULE (REDACTED) - CSL Behring UK Ltd#2
Not provided
AWARD SCHEDULE (REDACTED) - CSL Behring UK Ltd#2
Document
AWARD SCHEDULE (REDACTED) - BioCryst Ireland Ltd#2
Not provided
AWARD SCHEDULE (REDACTED) - BioCryst Ireland Ltd#2
Document
AWARD SCHEDULE (REDACTED) - Cipla EU Ltd#2
Not provided
AWARD SCHEDULE (REDACTED) - Cipla EU Ltd#2
Document
Awarded Suppliers - Name, Postcode and SME Indicator
Not provided
Awarded Suppliers - Name, Postcode and SME Indicator
Document
AWARD SCHEDULE (REDACTED) - Martindale Pharma#2
Not provided
AWARD SCHEDULE (REDACTED) - Martindale Pharma#2
Document
AWARD SCHEDULE (REDACTED) - Wockhardt UK Ltd#2
Not provided
AWARD SCHEDULE (REDACTED) - Wockhardt UK Ltd#2
Document
AWARD SCHEDULE (REDACTED) - Pharming Group NV#2
Not provided
AWARD SCHEDULE (REDACTED) - Pharming Group NV#2
Document
Contains public sector information licensed under the Open Government Licence v3.0.